Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]
-
* Corresponding author: Paul D Carey pcarey@sun.ac.za
BMC Psychiatry 2005, 5:5 doi:10.1186/1471-244X-5-5
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 12 Oct 2004 | |
| Reviewer's Report | Lawrence Price | 26 Oct 2004 | |
| Reviewer's Report | lorrin koran | 06 Nov 2004 | |
| Resubmission - Version 2 | 13 Dec 2004 | ||
| Resubmission - Version 3 | Manuscript | 13 Dec 2004 | |
| Reviewer's Report | lorrin koran | 18 Dec 2004 | |
| Reviewer's Report | Lawrence Price | 23 Dec 2004 | |
| Resubmission - Version 4 | Manuscript | Author's comment | 14 Jan 2005 |
| Published | 24 Jan 2005 |